RxSight (RXST) Net Cash Flow (2020 - 2026)

RxSight (RXST) has reported Net Cash Flow for 7 consecutive years, with -$4.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Cash Flow fell 134.23% year-over-year to -$4.2 million; the trailing twelve-month figure through Jun 2026 stood at -$27.0 million (down 269.4% YoY), and the FY2025 full-year result was $3.2 million, down 54.11% from the prior year.
• Net Cash Flow declined to -$4.2 million in Q2 2026 per RXST's latest filing, from -$2.4 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $29.6 million in Q2 2022 and bottomed at -$29.9 million in Q1 2022.
• Historically, Net Cash Flow has averaged -$614777.8 across 5 years, with a median of -$1.5 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Net Cash Flow surged 2886.04% in 2024, then sank 26952.78% in 2025.
• Over 5 years, Net Cash Flow stood at $2.9 million in 2022, then sank by 106.05% to -$173000.0 in 2023, then jumped by 120.81% to $36000.0 in 2024, then tumbled by 26952.78% to -$9.7 million in 2025, then soared by 56.3% to -$4.2 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$4.2 million, -$2.4 million, and -$9.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.